Oppenheimer & Co’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,290
| Closed | -$202K | – | 1577 |
|
|
2024
Q4 | $202K | Sell |
1,290
-40
| -3% | -$6.28K | ﹤0.01% | 1453 |
|
|
2024
Q3 | $236K | Hold |
1,330
| – | – | ﹤0.01% | 1343 |
|
|
2024
Q2 | $224K | Buy |
1,330
+10
| +0.8% | +$1.68K | ﹤0.01% | 1305 |
|
|
2024
Q1 | $220K | Buy |
1,320
+20
| +2% | +$3.33K | ﹤0.01% | 1301 |
|
|
2023
Q4 | $215K | Sell |
1,300
-750
| -37% | -$124K | ﹤0.01% | 1261 |
|
|
2023
Q3 | $319K | Sell |
2,050
-500
| -20% | -$77.9K | 0.01% | 1108 |
|
|
2023
Q2 | $398K | Sell |
2,550
-165
| -6% | -$25.7K | 0.01% | 1054 |
|
|
2023
Q1 | $440K | Buy |
2,715
+30
| +1% | +$4.86K | 0.01% | 993 |
|
|
2022
Q4 | $429K | Buy |
2,685
+280
| +12% | +$44.7K | 0.01% | 966 |
|
|
2022
Q3 | $339K | Sell |
2,405
-180
| -7% | -$25.4K | 0.01% | 1024 |
|
|
2022
Q2 | $377K | Buy |
+2,585
| New | +$377K | 0.01% | 1022 |
|